Category Archives: cardiology retractions
A convicted felon writes a paper on hotly debated diets. What could go wrong?
Pro-tip for journals and publishers: When you decide to publish a paper about a subject — say, diets — that you know will draw a great deal of scrutiny from vocal proponents of alternatives, make sure it’s as close to airtight as possible. And in the event that the paper turns out not to be … Continue reading A convicted felon writes a paper on hotly debated diets. What could go wrong?
Posted by in cardiology retractions
Harvard and the Brigham recommend 31 retractions for cardiac stem cell work
Retraction Watch readers may be familiar with the name Piero Anversa. Until several years ago, Anversa, a scientist at Harvard Medical School and the Brigham and Women’s Hospital, was a powerful figure in cardiac stem cell research. “For ten years, he ran everything,” says Jeffery Molkentin, a researcher at Cincinnati Children’s whose lab was among the … Continue reading Harvard and the Brigham recommend 31 retractions for cardiac stem cell work
Posted by in cardiology retractions, cardiovascular research, united states
Authors retract heart disease paper for “nonscientific reason”
Researchers have retracted a 2018 paper about the genetic underpinnings of heart disease from the FASEB Journal — and it’s not entirely clear why. The paywalled retraction notice simply cites a “nonscientific reason.” Cody Mooneyhan, the director of publications at the journal, declined to provide further details, and the authors have provided different accounts of … Continue reading Authors retract heart disease paper for “nonscientific reason”
Caught Our Notice: Using this research tool? You’d better ask first
Title: Patient Education After CABG: Are We Teaching the Wrong Information? What Caught Our Attention: We’ve written about the controversy surrounding a commonly used tool to measure whether patients are sticking to their drug regimen, known as the Morisky Medication Adherence Scale (MMAS-8). It can cost thousands of dollars — and using it without payment/permission […]
The post Caught Our Notice: Using this research tool? You’d better ask first appeared first on Retraction Watch.
Caught Our Notice: Columbia researcher up to five retractions
Title: Endotoxaemia during left ventricular assist device insertion: relationship between risk factors and outcome What Caught Our Attention: Robert J. Frumento first caught our notice in 2013, as a coauthor on a paper retracted with a nonspecific reference to author misconduct. Three years later, Frumento was clearly identified as having fabricated data and a master’s […]
The post Caught Our Notice: Columbia researcher up to five retractions appeared first on Retraction Watch.
Caught Our Notice: Wait…we wrote WHAT paper?
Title: Assessment of coronary heart diseases in diabetics in al-Madinah al-Munawarah What Caught Our Notice: We’ve seen researchers dinged for adding authors to papers who didn’t participate in the research, but it’s rare to have a notice say co-author signatures were forged. In a recent retraction, the first two authors said the signatures on the the […]
The post Caught Our Notice: Wait…we wrote WHAT paper? appeared first on Retraction Watch.
Reader complaints prompt retraction of meta-analysis of heart-failure drug
A cardiology journal has retracted a 2016 meta-analysis after the editors had an, ahem, change of heart about the rigor of the study. The article, “Ivabradine as adjuvant treatment for chronic heart failure,” was published in the International Journal of Cardiology, an Elsevier title. The authors, a group at the Federal University of São Paulo, […]
The post Reader complaints prompt retraction of meta-analysis of heart-failure drug appeared first on Retraction Watch.
Journal knew about problems in a high-profile study before it came out — and did nothing for over a month
In June, Gene Emery, a journalist for Reuters Health, was assigned to write a story about an upcoming paper in the Journal of the American College of Cardiology, set to come off embargo and be released to the public in a few days. Pretty quickly, he noticed something seemed off. Emery saw that the data […]
The post Journal knew about problems in a high-profile study before it came out — and did nothing for over a month appeared first on Retraction Watch.
Three figures in blood pressure paper were manipulated, says journal
A pharmacology journal has retracted a 2011 paper after concluding images in three figures had been manipulated. According to the British Journal of Pharmacology, four of the five authors claim they played no role in the manipulation. There is no comment from the remaining author, first author Ian Morecroft, a research associate at the University of […]
The post Three figures in blood pressure paper were manipulated, says journal appeared first on Retraction Watch.